Regeneron Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
REGN Regeneron Pharmaceuticals Inc
BNGOW Bionano Genomics Equity Warrants Exp 21 Sep 2023 *W EXP 09/21/2023
CVR Chicago Rivet & Machine Co
T AT&T Inc
HOMB Home BancShares Inc
ALG Alamo Group Inc
MGNX MacroGenics Inc
CBZ CBIZ Inc
PSEC Prospect Capital Corp
SPEC Spectralcast Inc
Go

Health Care : Biotechnology | Large Cap Blend
Company profile

Regeneron Pharmaceuticals, Inc. is an integrated biotechnology company that discovers, invents, develops, manufactures, and commercializes medicines for serious diseases. Its commercialized medicines and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, pain, hematologic conditions, infectious diseases, and rare diseases. The Company's marketed products include EYLEA (aflibercept) Injection, Dupixent (dupilumab) Injection, Libtayo (cemiplimab) Injection, Praluent (alirocumab) Injection, REGEN-COV, Kevzara (sarilumab) Solution for Subcutaneous Injection, Evkeeza (evinacumab) Injection, Inmazeb (atoltivimab, maftivimab, and odesivimab-ebgn) Injection, ARCALYST (rilonacept) Injection for Subcutaneous Use and ZALTRAP (ziv-aflibercept) Injection for Intravenous Infusion. Its product candidates in clinical development include REGN4018, REGN5668, and Fasinumab, among others.

Closing Price
$661.14
Day's Change
3.99 (0.61%)
Bid
--
Ask
--
B/A Size
--
Day's High
664.90
Day's Low
647.54
Volume
(Below Average)
Volume:
544,265

10-day average volume:
665,857
544,265
  • Prev Close
    657.15
  • Today's Open
    661.29
  • Day's Range
    647.54-664.90
  • Avg Vol (10-day)
    665.9K
  • Last (time)
    4:00p ET 05/20/22
  • Last (size)
    5
  • 52-Wk Range
    492.13 - 747.42
    LowHigh
  • (05/27/21 - 04/08/22)
    11.54%
  • 25.9%
  • Market Cap
    72.6B
  • Shares Outstanding
    109.8M
  • 70.56
  • 9.34x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.2
  • 86.06
  • (% of float 04/29/22)
    2.05

Latest News

May 21, 2022
7:00 am ET
PR Newswire
May 20, 2022
5:18 pm ET
MarketWatch
3:15 pm ET
PR Newswire
May 19, 2022
5:18 pm ET
MarketWatch
May 18, 2022
5:18 pm ET
MarketWatch
May 17, 2022
5:18 pm ET
MarketWatch
7:00 am ET
PR Newswire
7:00 am ET
PR Newswire
May 16, 2022
5:17 pm ET
MarketWatch
May 13, 2022
5:18 pm ET
MarketWatch
May 12, 2022
5:18 pm ET
MarketWatch
May 11, 2022
5:18 pm ET
MarketWatch
May 10, 2022
5:18 pm ET
MarketWatch
May 09, 2022
5:18 pm ET
MarketWatch
May 06, 2022
5:18 pm ET
MarketWatch
May 05, 2022
5:18 pm ET
MarketWatch
May 04, 2022
5:18 pm ET
MarketWatch
6:47 am ET
MarketWatch
6:41 am ET
MarketWatch
6:38 am ET
MarketWatch
6:37 am ET
MarketWatch
6:37 am ET
MarketWatch
May 03, 2022
5:18 pm ET
MarketWatch
May 02, 2022
5:19 pm ET
MarketWatch
4:15 pm ET
PR Newswire
April 29, 2022
5:18 pm ET
MarketWatch
April 28, 2022
5:18 pm ET
MarketWatch
April 27, 2022
5:18 pm ET
MarketWatch
April 26, 2022
5:18 pm ET
MarketWatch
April 25, 2022
5:18 pm ET
MarketWatch
April 22, 2022
5:18 pm ET
MarketWatch
7:51 am ET
MarketWatch
April 20, 2022
5:17 pm ET
MarketWatch
10:03 am ET
Newsfile
April 19, 2022
5:18 pm ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.